Based on these premises, it is not a surprise that behind the above-described mechanisms of ASCT2 expression modulation, mTOR may play a role of director as already suggested in the very first report dealing with ASCT2, LAT1 and cancer (Fuchs and Bode, 2005). This evidence concerns the gene SLC1A5 and cancer.